Loading
DI
Depomed Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by HIGGINS ARTHUR J, was filed 12 Nov 2019.
Depomed Inc: what insiders have been doing
Every trade that managers of Depomed Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Depomed Inc in twelve months, the latest record being from 11 May 2020.
The full history, which starts in 2016, counts 17 purchases against 22 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
130
Thresholds
n/a
Buy Volume
€919,229
17 ops. · all time
Sell Volume
€5M
22 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$204.6M
Net income-US$193.6M-94.6% margin
Last declaration on 11 May 2020
Declarations130 total
15,834 shares@ US$0.7914100.0% of flowCommon StockSEC:0001005201-20-000037:0
7,433 shares@ US$0.646720.3% of flowCommon StockSEC:0001005201-20-000027:1
25,370 shares0Common StockSEC:0001005201-20-000027:0
25,370 shares0Common StockSEC:0001005201-20-000025:0
7,433 shares0Common StockSEC:0001005201-20-000025:1
12,492 shares0Common StockSEC:0001005201-20-000023:0
14,394 shares0Common StockSEC:0001005201-20-000016:0
31,008 shares@ US$1.3520.5% of flowCommon StockSEC:0001005201-20-000012:1
9,545 shares@ US$1.3511.7% of flowCommon StockSEC:0001005201-20-000013:1
9,545 shares@ US$1.3554.1% of flowCommon StockSEC:0001005201-20-000011:1
97,412 shares0Common StockSEC:0001005201-20-000012:0
27,588 shares0Common StockSEC:0001005201-20-000013:0
27,588 shares0Common StockSEC:0001005201-20-000011:0
2,318 shares@ US$1.042.9% of flowCommon StockSEC:0001005201-20-000007:1
21,590 shares@ US$1.0410.9% of flowCommon StockSEC:0001005201-20-000006:1
6,700 shares0Common StockSEC:0001005201-20-000007:0
62,399 shares0Common StockSEC:0001005201-20-000006:0
34,860 shares0Common StockSEC:0001005201-19-000130:0
8,359 shares0Common StockSEC:0001005201-19-000131:0
10,213 shares@ US$0.762.1% of flowCommon StockSEC:0001005201-19-000130:1
2,449 shares@ US$0.761.6% of flowCommon StockSEC:0001005201-19-000131:1
25,000 shares@ US$0.734.8% of flowCommon StockSEC:0001005201-19-000125:0
Canonical exit: 10 Feb 2020 (T+90)
10,000 shares@ US$0.72596.1% of flowCommon StockSEC:0001005201-19-000126:0
Canonical exit: 9 Feb 2020 (T+90)
13,900 shares@ US$0.713100.0% of flowCommon StockSEC:0001005201-19-000127:0
Canonical exit: 9 Feb 2020 (T+90)
11,623 shares0Common StockSEC:0001005201-19-000109:0
25 of 130 declarations
About Depomed Inc
Depomed Inc is a pharmaceutical company focused on developing treatments primarily for pain management and central nervous system disorders.
